Breakthrough Berberine-Based Drug Shows Promise in Managing Type 2 Diabetes
Key Highlights: A New Era in Diabetes Management An innovative compound, berberine ursodeoxycholate (HTD180), has demonstrated significant glucose-lowering effects in adults with poorly controlled type 2 diabetes. Conducted in China, a phase II randomized clinical trial revealed promising results, positioning this drug as a potential game-changer in diabetes treatment. By week 12, participants receiving HTD180 […]
Breakthrough Berberine-Based Drug Shows Promise in Managing Type 2 Diabetes Read More »






